Who are Elimite™ Cream (permethrin) 5%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): SUP Lidocaine, Topiramate monotherapy, Anesthetic Topical Adhesive Synera, Transdermal Lidocaine Patch, Levobupivacaine 0.5% + epinephrin 1/200000, Ropivacaine 0,75% in PENG block.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/elimite-cream-permethrin-5.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Elimite™ Cream (permethrin) 5% — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Elimite™ Cream (permethrin) 5% (Elimite™ Cream (permethrin) 5%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Pyrethroid insecticide. Area: Dermatology / Parasitology.

phase 3 Pyrethroid insecticide Voltage-gated sodium channels Dermatology / Parasitology Small molecule Live · refreshed every 30 min

Target snapshot

Elimite™ Cream (permethrin) 5% (Elimite™ Cream (permethrin) 5%) — Encube Ethicals Pvt. Ltd.. Permethrin is a synthetic pyrethroid insecticide that disrupts sodium channel function in the nervous system of parasites, causing paralysis and death.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Elimite™ Cream (permethrin) 5% TARGET	Elimite™ Cream (permethrin) 5%	Encube Ethicals Pvt. Ltd.	phase 3	Pyrethroid insecticide	Voltage-gated sodium channels
SUP Lidocaine	SUP Lidocaine	University of Michigan	marketed	Local anesthetic	Voltage-gated sodium channels
Topiramate monotherapy	Topiramate monotherapy	Johnson & Johnson Taiwan Ltd	marketed	Anticonvulsant / Antiepileptic agent	GABA-A receptor; voltage-gated sodium channels
Anesthetic Topical Adhesive Synera	Anesthetic Topical Adhesive Synera	Brown, Theodore R., M.D., MPH	marketed	Topical local anesthetic	Voltage-gated sodium channels
Transdermal Lidocaine Patch	Transdermal Lidocaine Patch	University of Wisconsin, Madison	marketed	Local anesthetic	Voltage-gated sodium channels
Levobupivacaine 0.5% + epinephrin 1/200000	Levobupivacaine 0.5% + epinephrin 1/200000	University Hospital, Antwerp	marketed	Local anesthetic with vasoconstrictor	Voltage-gated sodium channels; alpha-adrenergic receptors
Ropivacaine 0,75% in PENG block	Ropivacaine 0,75% in PENG block	University of Liege	marketed	Local anesthetic (amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Pyrethroid insecticide class)

Encube Ethicals Pvt. Ltd. · 1 drug in this class
Infectopharm Arzneimittel GmbH · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Elimite™ Cream (permethrin) 5% — Competitive Intelligence Brief. https://druglandscape.com/ci/elimite-cream-permethrin-5. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab